May 7, 2014
Copenhagen, Denmark
Following the Mayo, Prometheus, and Myriad court decisions in the U.S., the life sciences community has been watching closely to see the breadth of impact these cases have on their industry. In March, the United States Patent and Trademark Office (USPTO) issued its long awaited Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of nature, Natural Phenomena, & Natural Products. During this seminar we will discuss how natural product and diagnostic method claims will be examined by the USPTO, as well as, practical advice on the types of claims that may be obtainable in the biotech, pharmaceutical and chemical fields.
Additionally, just 18 months after the AIA post-grant challenges went into effect, the USPTO has already received close to 1100 requests challenging the validity of issued U.S. patents. And the number of petitions continues to increase in the life sciences, medical device, and chemical areas, in what so far has been a very favorable jurisdiction for challengers. In view of this significant change in how the validity of a U.S. patent is being evaluated, we will also discuss best practice examples for successfully handling post-grant challenges.
This seminar will take place in Copenhagen, Denmark. Admission is free, but space is limited so please reserve a space as soon as possible. Email.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.